— Know what they know.
Not Investment Advice

DXCM NASDAQ

DexCom, Inc.
1W: +24.4% 1M: +13.4% 3M: -1.6% YTD: +8.1% 1Y: -17.7% 3Y: -39.4% 5Y: -13.7%
$72.10
+0.20 (+0.28%)
 
Weekly Expected Move ±6.1%
$54 $58 $62 $65 $69
NASDAQ · Healthcare · Medical - Devices · Alpha Radar Buy · Power 74 · $27.8B mcap · 384M float · 1.26% daily turnover · Short 46% of daily vol

📊 Key Metrics

TTM
$5B
Revenue
+16.1% YoY
$930M
Net Income
+73.8% YoY
$1B
Free Cash Flow
+148.5% YoY
62.9%
Gross Margin
21.4%
Op. Margin
16.7%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE38.4%
ROA14.5%
ROIC37.4%

Valuation

P/E29.8
P/B9.4
EV/EBITDA16.7

Leverage

Debt/Equity0.51
Current Ratio1.88
Interest Cov.86.8x

Quality Scores

Piotroski F8/9
Altman Z6.40
Beneish M-3.00

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms